Market
BIOTRONIK Neuro acquires Soin Neuroscience’s SCS IP portfolio
BIOTRONIK Neuro has acquired an intellectual property portfolio from Soin Neuroscience focused on spinal cord stimulation (SCS) technology. The deal expands BIOTRONIK's neuromodulation capabilities and IP footprint in the SCS market.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network